Literature DB >> 17906875

Beneficial effects of cardiac rehabilitation and exercise after percutaneous coronary intervention on hsCRP and inflammatory cytokines in CAD patients.

Young-Joo Kim1, Young-Oh Shin, Jun-Sang Bae, Jeong-Beom Lee, Joo-Hyun Ham, Youn-Jung Son, Jung-Kyu Kim, Chul Kim, Byoung-Kwon Lee, Jae-Keun Oh, Timothy Othman, Young-Ki Min, Hun-Mo Yang.   

Abstract

Recent studies showed that tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), as well as high-sensitive C-reactive protein (hsCRP) levels are predictive factors of cardiovascular risk. However, the effect of cardiac rehabilitation (CR) intervention in coronary artery disease (CAD) patients on these factors is not known. The aim of this study was to evaluate the effects of CR and exercise on hsCRP and inflammatory cytokine levels in patients with CAD after percutaneous coronary intervention (PCI). CAD patients who underwent PCI were divided into a CR and exercise group (CRE, n = 29) or a control group (CON, n = 10). CR and exercise consisted of 6 weeks supervised exercise training and 8 weeks home-based, self-managed exercise. Compared to pre-experimental levels, TNF-alpha (by 20.4%; p = 0.006) and IL-6 (by 49.0%; p < 0.0001), as well as hsCRP (by 59.4%; p < 0.0001), were markedly decreased after CR and exercise in CAD patients but not in control group, except for IL-6 (by 41.6%; p = 0.001). However, there was no significant alteration of adiposity-related variables such as BMI, percent body fat, and waist circumferences, in both groups. We suggest that CR and exercise in CAD patients after PCI induce significant reduction in hsCRP and inflammatory cytokines (TNF-alpha and IL-6), and marked increase in exercise tolerance and capacity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906875     DOI: 10.1007/s00424-007-0356-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  40 in total

1.  Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.

Authors:  Christoph Bickel; Hans J Rupprecht; Stefan Blankenberg; Christine Espiniola-Klein; Axel Schlitt; Gerd Rippin; Gerd Hafner; Rainer Treude; Hisham Othman; Klaus-Peter Hofmann; Jürgen Meyer
Journal:  Am J Cardiol       Date:  2002-04-15       Impact factor: 2.778

2.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Authors:  M A Albert; E Danielson; N Rifai; P M Ridker
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

3.  Soluble P-selectin and the risk of future cardiovascular events.

Authors:  P M Ridker; J E Buring; N Rifai
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

4.  C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.

Authors:  H Koukkunen; K Penttilä; A Kemppainen; M Halinen; I Penttila; T Rantanen; K Pyörälä
Journal:  Ann Med       Date:  2001-02       Impact factor: 4.709

5.  Effects of a two-week, hospitalized phase II cardiac rehabilitation program on physical capacity, lipid profiles and psychological variables in patients with acute myocardial infarction.

Authors:  T Yoshida; K Yoshida; C Yamamoto; M Nagasaka; H Tadaura; T Meguro; T Sato; M M Kohzuki
Journal:  Jpn Circ J       Date:  2001-02

6.  Early upregulation of endothelial adhesion molecules in obese hypertensive men.

Authors:  C Ferri; G Desideri; M Valenti; C Bellini; M Pasin; A Santucci; G De Mattia
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

7.  Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease.

Authors:  J K Smith; R Dykes; J E Douglas; G Krishnaswamy; S Berk
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

8.  Elevated levels of interleukin-6 in unstable angina.

Authors:  L M Biasucci; A Vitelli; G Liuzzo; S Altamura; G Caligiuri; C Monaco; A G Rebuzzi; G Ciliberto; A Maseri
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

9.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

10.  Effects of a comprehensive cardiac rehabilitation program on quality of life and exercise tolerance in women: A retrospective analysis.

Authors:  Michael D Kennedy; Mark Haykowsky; Bill Daub; Karen Van Lohuizen; Grant Knapik; Bill Black
Journal:  Curr Control Trials Cardiovasc Med       Date:  2003-04-01
View more
  13 in total

1.  A yearlong exercise intervention decreases CRP among obese postmenopausal women.

Authors:  Peter T Campbell; Kristin L Campbell; Mark H Wener; Brent L Wood; John D Potter; Anne McTiernan; Cornelia M Ulrich
Journal:  Med Sci Sports Exerc       Date:  2009-08       Impact factor: 5.411

Review 2.  Global availability of cardiac rehabilitation.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

3.  Exercise protects against PCB-induced inflammation and associated cardiovascular risk factors.

Authors:  Margaret O Murphy; Michael C Petriello; Sung Gu Han; Manjula Sunkara; Andrew J Morris; Karyn Esser; Bernhard Hennig
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-15       Impact factor: 4.223

4.  Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis.

Authors:  Hu Zhang; Rong Chang
Journal:  J Sports Sci Med       Date:  2019-06-01       Impact factor: 2.988

5.  Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease.

Authors:  W Swardfager; N Herrmann; S Marzolini; M Saleem; P Shammi; P I Oh; P R Albert; M Daigle; A Kiss; K L Lanctôt
Journal:  Brain Behav Immun       Date:  2011-04-30       Impact factor: 7.217

6.  The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.

Authors:  Theresa M Beckie; Jason W Beckstead; Maureen W Groer
Journal:  J Cardiovasc Nurs       Date:  2010 Jan-Feb       Impact factor: 2.083

7.  Voluntary running suppresses proinflammatory cytokines and bone marrow endothelial progenitor cell levels in apolipoprotein-E-deficient mice.

Authors:  Olujimi A Ajijola; Chunming Dong; Edward E Herderick; Qi Ma; Pascal J Goldschmidt-Clermont; Zhen Yan
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

8.  An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE⁻/⁻ mice.

Authors:  Liliana Cesar; Samuel Vasallo Suarez; Jennipher Adi; Nikhil Adi; Roberto Vazquez-Padron; Hong Yu; Qi Ma; Pascal J Goldschmidt-Clermont; Arthur Agatston; Paul Kurlansky; Keith A Webster
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

9.  Voluntary exercise decreases atherosclerosis in nephrectomised ApoE knockout mice.

Authors:  Cecilia M Shing; Robert G Fassett; Jonathan M Peake; Jeff S Coombes
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial.

Authors:  Stefan Heinze-Milne; Volodko Bakowsky; Nicholas Giacomantonio; Scott A Grandy
Journal:  BMJ Open       Date:  2017-12-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.